Ribociclib + letrozole for first-line treatment of HR+, HER2− ABC: efficacy, safety, and pharmacokineticsF. André,S.M. Stemmer,G.N. Hortobagyi,H.A. Burris,S. Paluch-Shimon,M. Campone,C. Villanueva,A. Chan,E. Wist,N. Marschner,T. Bachelot,S. Blau, W. Janni,S. Verma, P. Conte,S. Dhuria,S. Yang, M. Stegert,C. Germa, C.L. ArteagaEuropean Journal of Cancer（2016）引用 4|浏览36暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
